ArticleNPJ digital medicine2025
Anatomically-guided Masked Autoencoder with Domain-Adaptive Prompting (AMAP) for multimodal cerebral aneurysm detection and segmentation.
Article in NPJ digital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Artificial intelligence in neurovascular surgery: advancing diagnosis, treatment, and outcomes.Frontiers in surgery · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Intracranial cerebral aneurysms are life-threatening vascular abnormalities whose rupture may result in subarachnoid hemorrhage, stroke, or death. Detecting and delineating aneurysms, particularly those under 5 mm, is essential for risk assessment and treatment planning but remains difficult for current AI approaches. Existing methods often fail to identify small aneurysms, mis-segment vascular bifurcations, and show reduced performance across imaging centers and modalities. We introduce AMAP (Anatomically-guided Masked Autoencoder with domain-adaptive Prompting), a framework for reliable cerebral aneurysm analysis. AMAP incorporates three key components: (1) anatomy-guided MAE pretraining, which directs self-supervised reconstruction toward cerebrovascular structures and captures subtle aneurysm morphology; (2) domain-adaptive prompting, which combines global vascular priors with case-specific prompts to enhance robustness across domains; and (3) boundary-aware contrastive learning with GS-EMA, which aligns vessel boundaries and mitigates false positives at bifurcations. Experiments on three public datasets (ADAM, IntrA, CQ500) and additional unseen domains demonstrate that AMAP surpasses CNN-, Transformer-, and foundation-based baselines, as well as domain generalization methods. It achieves 3-5% higher Dice scores, reduces false positives per case by about 20%, and improves calibration. Qualitative results further show accurate boundary preservation and consistent detection of small aneurysms overlooked by other methods. These findings suggest that AMAP is a step toward trustworthy and clinically applicable AI for aneurysm screening.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.